Moderna stock falls 20% after record rally as valuation concerns emerge

Moderna shares fell sharply in trading on Thursday as investors took profits after the biotechnology company posted its biggest one-day gain following positive Phase 3 cancer vaccine results. The retr...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。